Cargando…

Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD

BACKGROUND AND AIMS: Bile acids are hepatic metabolites and have many properties considered to be relevant to the pathophysiology of NAFLD. Circulating levels of the intestinal microbiome‐modified bile acid deoxycholate are increased in cirrhosis. APPROACH AND RESULTS: To further elucidate the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smirnova, Ekaterina, Muthiah, Mark D., Narayan, Nicole, Siddiqui, Mohamad S., Puri, Puneet, Luketic, Velimir A., Contos, Melissa J., Idowu, Michael, Chuang, Jen‐Chieh, Billin, Andrew N., Huss, Ryan S., Myers, Robert P., Boyett, Sherry, Seneshaw, Mulugeta, Min, Hae‐Ki, Mirshahi, Faridodin, Sanyal, Arun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653520/ https://www.ncbi.nlm.nih.gov/pubmed/35561146 http://dx.doi.org/10.1002/hep.32568

Ejemplares similares

Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
por: Muthiah, Mark D., et al.
Publicado: (2022)

Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
por: Ng, Nicole, et al.
Publicado: (2023)

Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022)

Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
por: Kriss, Michael, et al.
Publicado: (2020)

An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
por: Luo, Yi, et al.
Publicado: (2018)

The role of bile acid metabolism in the occurrence and development of NAFLD
por: Bing, Hao, et al.
Publicado: (2022)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease
por: Hoang, Stephen A., et al.
Publicado: (2019)

Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes
por: Weaver, Michael J., et al.
Publicado: (2020)

A Review of the Physiological and Immunological Functions of Biliary Epithelial Cells: Targets for Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis and Drug-induced Ductopenias
por: Wu, Chih-Te, et al.
Publicado: (2004)

The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma
por: Koelsch, Nicholas, et al.
Publicado: (2023)

Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Tauriainen, Milla-Maria, et al.
Publicado: (2018)

Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
por: Liu, Jianjun, et al.
Publicado: (2023)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

LPCN 1144 Resolves NAFLD in Hypogonadal Males
por: Albhaisi, Somaya, et al.
Publicado: (2020)

Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
por: Nah, Benjamin Kai Yi, et al.
Publicado: (2022)

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
por: Gottlieb, Aline, et al.
Publicado: (2019)

Enemy at the water cooler: real-life stories of insider threats and Enterprise Security Management countermeasures
por: Contos, Brian T
Publicado: (2006)

Physical and logical security convergence: powered by enterprise security management
por: Contos, Brian T
Publicado: (2007)

Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Plat, Jogchum, et al.
Publicado: (2018)

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
por: Asgharpour, Amon, et al.
Publicado: (2016)

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2017)

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2020)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
por: Kobayashi, Yoshinao, et al.
Publicado: (2017)

Differential fuel utilization in liver transplant recipients and its relationship with non‐alcoholic fatty liver disease
por: Siddiqui, Mohammad S., et al.
Publicado: (2022)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model
por: Huang, Wenli, et al.
Publicado: (2020)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring
por: Guo, Qing, et al.
Publicado: (2021)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
por: Sanyal, Arun J., et al.
Publicado: (2023)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
por: Juárez-Fernández, María, et al.
Publicado: (2021)

Randomized placebo‐controlled trial of losartan for pediatric NAFLD
por: Vos, Miriam B., et al.
Publicado: (2022)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

OR10-5 Fructose Consumption and NAFLD in US Adult Population of NHANES 17-18
por: Kermah, Dulcie, et al.
Publicado: (2022)

Identification of HLA-A2–restricted CD8(+) Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells
por: Kita, Hiroto, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_evcoec7kp9v2je5umnn2l9pkp8